EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Nonadherence to GLP‐1 Receptor Agonists Among Individuals With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Efrata A Shegena iD, Mekdes Kiflu, Muktar Ahmed iD, Akshaya Srikanth Bhagavathula iD, Tadesse M Abegaz

Obesity Reviews · 26.07.2026

DOI: 10.1111/obr.70200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 26.07.2026. Verfasst von Efrata A Shegena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucagon‐like peptide 1 (GLP‐1) agonists are widely used for obesity management in patients with or without diabetes. However, treatment persistence is often limited due to adverse drug reactions (ADRs). Understanding adherence patterns in randomized controlled trials (RCTs) is crucial for predicting real‐world treatment acceptance.

Objective

To estimate the pooled nonadherence rates and reasons for nonadherence to GLP‐1 agonists in overweight or patients with obesity participating in RCTs.

Methods

A systematic review and meta‐analysis of RCTs was conducted to evaluate nonadherence to GLP‐1 receptor agonists. A literature search was performed in PubMed, Embase, and Web of Science from inception to October 2, 2024. Studies were included if they evaluated GLP‐1 receptor agonists for overweight or obesity management and reported adherence outcomes.

Results

The pooled RR for nonadherence to GLP‐1 receptor agonists was 0.63 (95% CI: 0.48, 0.82, p = 0.01), indicating a 37% lower risk of nonadherence compared with the control group. However, ADR‐induced nonadherence was significantly higher in the GLP‐1 group (RR: 2.29 [95% CI: 1.47, 3.56, p = 0.04]), particularly due to gastrointestinal side effects. Nonadherence due to loss to follow‐up was lower in the GLP‐1 group (RR: 0.43 [95% CI: 0.27, 0.71, p = 0.18]).

Conclusion

GLP‐1 receptor agonists were associated with a lower overall nonadherence rate in RCTs compared with control treatments, suggesting higher persistence. However, ADR‐related nonadherence was significantly higher, particularly due to gastrointestinal side effects. These findings highlight the need for strategies to improve treatment tolerability and adherence in real‐world settings.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1 receptor agonistsadverse drug reactionsmeta‐analysisnonadherenceobesity managementrandomized controlled trials

Autor:innen und Institutionen

  • Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Pharmacy, Debre Markos University, Debre Markos, Ethiopia.
  • College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Public Health Program, School of Health Systems & Innovation, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota, USA.
  • School of Pharmacy, The University of Texas, El Paso, Texas, USA.

ORCID-Profile: Efrata A Shegena, Muktar Ahmed, Akshaya Srikanth Bhagavathula

Zitieren

APA

Shegena, E. A., Kiflu, M., Ahmed, M., Bhagavathula, A. S., & Abegaz, T. M. (2026). Nonadherence to GLP‐1 Receptor Agonists Among Individuals With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Obesity Reviews. https://doi.org/10.1111/obr.70200

Vancouver

Shegena EA, Kiflu M, Ahmed M, Bhagavathula AS, Abegaz TM. Nonadherence to GLP‐1 Receptor Agonists Among Individuals With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Obesity Reviews. 2026. doi:10.1111/obr.70200

BibTeX
@article{Shegena2026,
  author = {Shegena, Efrata A and Kiflu, Mekdes and Ahmed, Muktar and Bhagavathula, Akshaya Srikanth and Abegaz, Tadesse M},
  title = {Nonadherence to GLP‐1 Receptor Agonists Among Individuals With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
  journal = {Obesity Reviews},
  year = {2026},
  doi = {10.1111/obr.70200}
}
Kostenlos starten →